✦ LIBER ✦

PET studies of hippocampal metabolism in patients with Alzheimer's disease during an olfactory memory task

✍ Scribed by M. S. Buchsbaum; Pat Kesslak; C. Cotman; G. Lynch; Helena Chui; J. Wu; Nancy Sicotte; F. Halzett

Publisher: Springer
Year: 1989
Tongue: English
Weight: 63 KB
Volume: 1
Category: Article
ISSN: 1435-1463
DOI: 10.1007/bf02312210

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Longitudinal PET evaluation of cerebral

Longitudinal PET evaluation of cerebral glucose metabolism in rivastigmine treated patients with mild Alzheimer’s disease

✍ E. Stefanova; A. Wall; O. Almkvist; A. Nilsson; A. Forsberg; B. Långström; A. No 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 276 KB

Neural correlates of verbal episodic mem

Neural correlates of verbal episodic memory in patients with MCI and Alzheimer's disease––a VBM study

✍ Dirk T. Leube; Susanne Weis; Kathrin Freymann; Michael Erb; Frank Jessen; Reinha 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 101 KB 👁 1 views

## Abstract ## Objective The hippocampus is a key area for episodic memory processes. Hippocampal atrophy is a hallmark feature of Alzheimer's disease (AD). We used a new and automatized morphometric technique to better characterize brain atrophy in subjects with different levels of cognitive defi

Efficacy and safety of donepezil over 3

Efficacy and safety of donepezil over 3 years: an open-label, multicentre study in patients with Alzheimer's disease

✍ A. Burns; S. Gauthier; C. Perdomo 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 130 KB 👁 2 views

## Abstract ## Objective This 132‐week, open‐label extension study assessed the long‐term efficacy and safety of donepezil in 579 patients with mild to moderate Alzheimer's disease (AD) who had previously participated in a 24‐week double‐blind study of 5 or 10 mg/day donepezil __vs__ placebo. ##